Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Research Report 2026(Status and Outlook)
The global Hiv Integrase Strand Transfer Inhibitors (Insti) market size was estimated at USD 6830.45 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hiv Integrase Strand Transfer Inhibitors (Insti) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hiv Integrase Strand Transfer Inhibitors (Insti) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hiv Integrase Strand Transfer Inhibitors (Insti) market.
Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Market Segmentation (by Type)
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Others
Market Segmentation (by Application)
Hospital
Clinic
Drug Center
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hiv Integrase Strand Transfer Inhibitors (Insti) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hiv Integrase Strand Transfer Inhibitors (Insti), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Hiv Integrase Strand Transfer Inhibitors (Insti) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hiv Integrase Strand Transfer Inhibitors (Insti) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hiv Integrase Strand Transfer Inhibitors (Insti) market.
Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)
Market Segmentation (by Type)
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Others
Market Segmentation (by Application)
Hospital
Clinic
Drug Center
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hiv Integrase Strand Transfer Inhibitors (Insti) Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hiv Integrase Strand Transfer Inhibitors (Insti) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hiv Integrase Strand Transfer Inhibitors (Insti), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hiv Integrase Strand Transfer Inhibitors (Insti)
1.2 Key Market Segments
1.2.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Segment by Type
1.2.2 Hiv Integrase Strand Transfer Inhibitors (Insti) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Product Life Cycle
3.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Manufacturers (2020-2025)
3.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Manufacturers (2020-2025)
3.5 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Competitive Situation and Trends
3.8.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hiv Integrase Strand Transfer Inhibitors (Insti) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) INDUSTRY CHAIN ANALYSIS
4.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hiv Integrase Strand Transfer Inhibitors (Insti) Market
5.7 ESG Ratings of Leading Companies
6 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Type (2020-2025)
6.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (2020-2025)
6.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price by Type (2020-2025)
7 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Sales by Application (2020-2025)
7.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) by Application (2020-2025)
7.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
8 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SALES BY REGION
8.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.1.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region
8.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.2.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.2.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.3 North America
8.3.1 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.3.2 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.4.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.5.2 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.6.2 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.7.2 Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET PRODUCTION BY REGION
9.1 Global Production of Hiv Integrase Strand Transfer Inhibitors (Insti) by Region(2020-2025)
9.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Region (2020-2025)
9.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production
9.4.1 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.4.2 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production
9.5.1 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.5.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (2020-2025)
9.6.1 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.6.2 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (2020-2025)
9.7.1 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.7.2 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adcock Ingram Limited
10.1.1 Adcock Ingram Limited Basic Information
10.1.2 Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.1.3 Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.1.4 Adcock Ingram Limited Business Overview
10.1.5 Adcock Ingram Limited SWOT Analysis
10.1.6 Adcock Ingram Limited Recent Developments
10.2 Affine Formulations Limited
10.2.1 Affine Formulations Limited Basic Information
10.2.2 Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.2.3 Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.2.4 Affine Formulations Limited Business Overview
10.2.5 Affine Formulations Limited SWOT Analysis
10.2.6 Affine Formulations Limited Recent Developments
10.3 Aurobindo Pharma
10.3.1 Aurobindo Pharma Basic Information
10.3.2 Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.3.3 Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.3.4 Aurobindo Pharma Business Overview
10.3.5 Aurobindo Pharma SWOT Analysis
10.3.6 Aurobindo Pharma Recent Developments
10.4 Biocon Limited
10.4.1 Biocon Limited Basic Information
10.4.2 Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.4.3 Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.4.4 Biocon Limited Business Overview
10.4.5 Biocon Limited Recent Developments
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Basic Information
10.5.2 Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.5.3 Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.5.4 Bristol-Myers Squibb Business Overview
10.5.5 Bristol-Myers Squibb Recent Developments
10.6 Cipla
10.6.1 Cipla Basic Information
10.6.2 Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.6.3 Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.6.4 Cipla Business Overview
10.6.5 Cipla Recent Developments
10.7 Emcure Pharmaceuticals
10.7.1 Emcure Pharmaceuticals Basic Information
10.7.2 Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.7.3 Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.7.4 Emcure Pharmaceuticals Business Overview
10.7.5 Emcure Pharmaceuticals Recent Developments
10.8 Flamingo Pharmaceuticals Limited
10.8.1 Flamingo Pharmaceuticals Limited Basic Information
10.8.2 Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.8.3 Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.8.4 Flamingo Pharmaceuticals Limited Business Overview
10.8.5 Flamingo Pharmaceuticals Limited Recent Developments
10.9 Gilead Sciences
10.9.1 Gilead Sciences Basic Information
10.9.2 Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.9.3 Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.9.4 Gilead Sciences Business Overview
10.9.5 Gilead Sciences Recent Developments
10.10 Hetero Drugs
10.10.1 Hetero Drugs Basic Information
10.10.2 Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.10.3 Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.10.4 Hetero Drugs Business Overview
10.10.5 Hetero Drugs Recent Developments
10.11 IPCA Laboratories
10.11.1 IPCA Laboratories Basic Information
10.11.2 IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.11.3 IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.11.4 IPCA Laboratories Business Overview
10.11.5 IPCA Laboratories Recent Developments
10.12 Janssen Pharmaceutica (Johnson and Johnson)
10.12.1 Janssen Pharmaceutica (Johnson and Johnson) Basic Information
10.12.2 Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.12.3 Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.12.4 Janssen Pharmaceutica (Johnson and Johnson) Business Overview
10.12.5 Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
10.13 LAURUS Labs
10.13.1 LAURUS Labs Basic Information
10.13.2 LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.13.3 LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.13.4 LAURUS Labs Business Overview
10.13.5 LAURUS Labs Recent Developments
10.14 Medisist Pharma
10.14.1 Medisist Pharma Basic Information
10.14.2 Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.14.3 Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.14.4 Medisist Pharma Business Overview
10.14.5 Medisist Pharma Recent Developments
10.15 Merck
10.15.1 Merck Basic Information
10.15.2 Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.15.3 Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.15.4 Merck Business Overview
10.15.5 Merck Recent Developments
10.16 Mylan
10.16.1 Mylan Basic Information
10.16.2 Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.16.3 Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.16.4 Mylan Business Overview
10.16.5 Mylan Recent Developments
10.17 Ranbaxy Pharmaceuticals
10.17.1 Ranbaxy Pharmaceuticals Basic Information
10.17.2 Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.17.3 Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.17.4 Ranbaxy Pharmaceuticals Business Overview
10.17.5 Ranbaxy Pharmaceuticals Recent Developments
10.18 Shanghai Desano Pharmaceuticals
10.18.1 Shanghai Desano Pharmaceuticals Basic Information
10.18.2 Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.18.3 Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.18.4 Shanghai Desano Pharmaceuticals Business Overview
10.18.5 Shanghai Desano Pharmaceuticals Recent Developments
10.19 ViiV Healthcare (GSK)
10.19.1 ViiV Healthcare (GSK) Basic Information
10.19.2 ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.19.3 ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.19.4 ViiV Healthcare (GSK) Business Overview
10.19.5 ViiV Healthcare (GSK) Recent Developments
11 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET FORECAST BY REGION
11.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast
11.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country
11.2.3 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region
11.2.4 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hiv Integrase Strand Transfer Inhibitors (Insti) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2026-2035)
12.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2026-2035)
12.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Application (2026-2035)
12.2.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) Forecast by Application
12.2.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hiv Integrase Strand Transfer Inhibitors (Insti)
1.2 Key Market Segments
1.2.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Segment by Type
1.2.2 Hiv Integrase Strand Transfer Inhibitors (Insti) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Product Life Cycle
3.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Manufacturers (2020-2025)
3.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Manufacturers (2020-2025)
3.5 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Competitive Situation and Trends
3.8.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hiv Integrase Strand Transfer Inhibitors (Insti) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) INDUSTRY CHAIN ANALYSIS
4.1 Hiv Integrase Strand Transfer Inhibitors (Insti) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hiv Integrase Strand Transfer Inhibitors (Insti) Market
5.7 ESG Ratings of Leading Companies
6 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Type (2020-2025)
6.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (2020-2025)
6.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price by Type (2020-2025)
7 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Sales by Application (2020-2025)
7.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) by Application (2020-2025)
7.4 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
8 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SALES BY REGION
8.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.1.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region
8.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.2.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.2.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.3 North America
8.3.1 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.3.2 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.4.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.5.2 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country
8.6.2 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region
8.7.2 Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET PRODUCTION BY REGION
9.1 Global Production of Hiv Integrase Strand Transfer Inhibitors (Insti) by Region(2020-2025)
9.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Region (2020-2025)
9.3 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production
9.4.1 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.4.2 North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production
9.5.1 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.5.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (2020-2025)
9.6.1 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.6.2 Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (2020-2025)
9.7.1 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production Growth Rate (2020-2025)
9.7.2 China Hiv Integrase Strand Transfer Inhibitors (Insti) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adcock Ingram Limited
10.1.1 Adcock Ingram Limited Basic Information
10.1.2 Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.1.3 Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.1.4 Adcock Ingram Limited Business Overview
10.1.5 Adcock Ingram Limited SWOT Analysis
10.1.6 Adcock Ingram Limited Recent Developments
10.2 Affine Formulations Limited
10.2.1 Affine Formulations Limited Basic Information
10.2.2 Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.2.3 Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.2.4 Affine Formulations Limited Business Overview
10.2.5 Affine Formulations Limited SWOT Analysis
10.2.6 Affine Formulations Limited Recent Developments
10.3 Aurobindo Pharma
10.3.1 Aurobindo Pharma Basic Information
10.3.2 Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.3.3 Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.3.4 Aurobindo Pharma Business Overview
10.3.5 Aurobindo Pharma SWOT Analysis
10.3.6 Aurobindo Pharma Recent Developments
10.4 Biocon Limited
10.4.1 Biocon Limited Basic Information
10.4.2 Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.4.3 Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.4.4 Biocon Limited Business Overview
10.4.5 Biocon Limited Recent Developments
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Basic Information
10.5.2 Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.5.3 Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.5.4 Bristol-Myers Squibb Business Overview
10.5.5 Bristol-Myers Squibb Recent Developments
10.6 Cipla
10.6.1 Cipla Basic Information
10.6.2 Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.6.3 Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.6.4 Cipla Business Overview
10.6.5 Cipla Recent Developments
10.7 Emcure Pharmaceuticals
10.7.1 Emcure Pharmaceuticals Basic Information
10.7.2 Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.7.3 Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.7.4 Emcure Pharmaceuticals Business Overview
10.7.5 Emcure Pharmaceuticals Recent Developments
10.8 Flamingo Pharmaceuticals Limited
10.8.1 Flamingo Pharmaceuticals Limited Basic Information
10.8.2 Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.8.3 Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.8.4 Flamingo Pharmaceuticals Limited Business Overview
10.8.5 Flamingo Pharmaceuticals Limited Recent Developments
10.9 Gilead Sciences
10.9.1 Gilead Sciences Basic Information
10.9.2 Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.9.3 Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.9.4 Gilead Sciences Business Overview
10.9.5 Gilead Sciences Recent Developments
10.10 Hetero Drugs
10.10.1 Hetero Drugs Basic Information
10.10.2 Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.10.3 Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.10.4 Hetero Drugs Business Overview
10.10.5 Hetero Drugs Recent Developments
10.11 IPCA Laboratories
10.11.1 IPCA Laboratories Basic Information
10.11.2 IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.11.3 IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.11.4 IPCA Laboratories Business Overview
10.11.5 IPCA Laboratories Recent Developments
10.12 Janssen Pharmaceutica (Johnson and Johnson)
10.12.1 Janssen Pharmaceutica (Johnson and Johnson) Basic Information
10.12.2 Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.12.3 Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.12.4 Janssen Pharmaceutica (Johnson and Johnson) Business Overview
10.12.5 Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
10.13 LAURUS Labs
10.13.1 LAURUS Labs Basic Information
10.13.2 LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.13.3 LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.13.4 LAURUS Labs Business Overview
10.13.5 LAURUS Labs Recent Developments
10.14 Medisist Pharma
10.14.1 Medisist Pharma Basic Information
10.14.2 Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.14.3 Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.14.4 Medisist Pharma Business Overview
10.14.5 Medisist Pharma Recent Developments
10.15 Merck
10.15.1 Merck Basic Information
10.15.2 Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.15.3 Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.15.4 Merck Business Overview
10.15.5 Merck Recent Developments
10.16 Mylan
10.16.1 Mylan Basic Information
10.16.2 Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.16.3 Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.16.4 Mylan Business Overview
10.16.5 Mylan Recent Developments
10.17 Ranbaxy Pharmaceuticals
10.17.1 Ranbaxy Pharmaceuticals Basic Information
10.17.2 Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.17.3 Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.17.4 Ranbaxy Pharmaceuticals Business Overview
10.17.5 Ranbaxy Pharmaceuticals Recent Developments
10.18 Shanghai Desano Pharmaceuticals
10.18.1 Shanghai Desano Pharmaceuticals Basic Information
10.18.2 Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.18.3 Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.18.4 Shanghai Desano Pharmaceuticals Business Overview
10.18.5 Shanghai Desano Pharmaceuticals Recent Developments
10.19 ViiV Healthcare (GSK)
10.19.1 ViiV Healthcare (GSK) Basic Information
10.19.2 ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
10.19.3 ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Market Performance
10.19.4 ViiV Healthcare (GSK) Business Overview
10.19.5 ViiV Healthcare (GSK) Recent Developments
11 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET FORECAST BY REGION
11.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast
11.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country
11.2.3 Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region
11.2.4 South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hiv Integrase Strand Transfer Inhibitors (Insti) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2026-2035)
12.1.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2026-2035)
12.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Forecast by Application (2026-2035)
12.2.1 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) Forecast by Application
12.2.2 Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (M USD)
Table 4. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application
Table 5. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Comparison by Region (M USD)
Table 6. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hiv Integrase Strand Transfer Inhibitors (Insti) as of 2025)
Table 11. Global Market Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Type (K Units)
Table 27. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (M USD)
Table 28. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Type (2020-2025)
Table 29. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Type (2020-2025)
Table 30. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) by Type (2020-2025)
Table 31. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Type (2020-2025)
Table 32. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Application
Table 34. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application
Table 35. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Application (2020-2025) & (K Units)
Table 36. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application (2020-2025)
Table 37. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application (2020-2025)
Table 39. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
Table 40. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 41. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region (2020-2025)
Table 42. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025)
Table 44. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 45. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 51. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) by Region(2020-2025)
Table 55. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Region (2020-2025)
Table 57. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adcock Ingram Limited Basic Information
Table 63. Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 64. Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adcock Ingram Limited Business Overview
Table 66. Adcock Ingram Limited SWOT Analysis
Table 67. Adcock Ingram Limited Recent Developments
Table 68. Affine Formulations Limited Basic Information
Table 69. Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 70. Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Affine Formulations Limited Business Overview
Table 72. Affine Formulations Limited SWOT Analysis
Table 73. Affine Formulations Limited Recent Developments
Table 74. Aurobindo Pharma Basic Information
Table 75. Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 76. Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Aurobindo Pharma Business Overview
Table 78. Aurobindo Pharma SWOT Analysis
Table 79. Aurobindo Pharma Recent Developments
Table 80. Biocon Limited Basic Information
Table 81. Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 82. Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biocon Limited Business Overview
Table 84. Biocon Limited Recent Developments
Table 85. Bristol-Myers Squibb Basic Information
Table 86. Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 87. Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Recent Developments
Table 90. Cipla Basic Information
Table 91. Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 92. Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Cipla Business Overview
Table 94. Cipla Recent Developments
Table 95. Emcure Pharmaceuticals Basic Information
Table 96. Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 97. Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Emcure Pharmaceuticals Business Overview
Table 99. Emcure Pharmaceuticals Recent Developments
Table 100. Flamingo Pharmaceuticals Limited Basic Information
Table 101. Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 102. Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Flamingo Pharmaceuticals Limited Business Overview
Table 104. Flamingo Pharmaceuticals Limited Recent Developments
Table 105. Gilead Sciences Basic Information
Table 106. Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 107. Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Gilead Sciences Business Overview
Table 109. Gilead Sciences Recent Developments
Table 110. Hetero Drugs Basic Information
Table 111. Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 112. Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hetero Drugs Business Overview
Table 114. Hetero Drugs Recent Developments
Table 115. IPCA Laboratories Basic Information
Table 116. IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 117. IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. IPCA Laboratories Business Overview
Table 119. IPCA Laboratories Recent Developments
Table 120. Janssen Pharmaceutica (Johnson and Johnson) Basic Information
Table 121. Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 122. Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Janssen Pharmaceutica (Johnson and Johnson) Business Overview
Table 124. Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
Table 125. LAURUS Labs Basic Information
Table 126. LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 127. LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. LAURUS Labs Business Overview
Table 129. LAURUS Labs Recent Developments
Table 130. Medisist Pharma Basic Information
Table 131. Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 132. Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Medisist Pharma Business Overview
Table 134. Medisist Pharma Recent Developments
Table 135. Merck Basic Information
Table 136. Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 137. Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Merck Business Overview
Table 139. Merck Recent Developments
Table 140. Mylan Basic Information
Table 141. Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 142. Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mylan Business Overview
Table 144. Mylan Recent Developments
Table 145. Ranbaxy Pharmaceuticals Basic Information
Table 146. Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 147. Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Ranbaxy Pharmaceuticals Business Overview
Table 149. Ranbaxy Pharmaceuticals Recent Developments
Table 150. Shanghai Desano Pharmaceuticals Basic Information
Table 151. Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 152. Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Shanghai Desano Pharmaceuticals Business Overview
Table 154. Shanghai Desano Pharmaceuticals Recent Developments
Table 155. ViiV Healthcare (GSK) Basic Information
Table 156. ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 157. ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. ViiV Healthcare (GSK) Business Overview
Table 159. ViiV Healthcare (GSK) Recent Developments
Table 160. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (M USD)
Table 4. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application
Table 5. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Comparison by Region (M USD)
Table 6. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hiv Integrase Strand Transfer Inhibitors (Insti) as of 2025)
Table 11. Global Market Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Type (K Units)
Table 27. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Type (M USD)
Table 28. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Type (2020-2025)
Table 29. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Type (2020-2025)
Table 30. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) by Type (2020-2025)
Table 31. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Type (2020-2025)
Table 32. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) by Application
Table 34. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application
Table 35. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Application (2020-2025) & (K Units)
Table 36. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application (2020-2025)
Table 37. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application (2020-2025)
Table 39. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
Table 40. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 41. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region (2020-2025)
Table 42. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025)
Table 44. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 45. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Country (2020-2025) & (K Units)
Table 51. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) by Region(2020-2025)
Table 55. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Market Share by Region (2020-2025)
Table 57. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adcock Ingram Limited Basic Information
Table 63. Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 64. Adcock Ingram Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adcock Ingram Limited Business Overview
Table 66. Adcock Ingram Limited SWOT Analysis
Table 67. Adcock Ingram Limited Recent Developments
Table 68. Affine Formulations Limited Basic Information
Table 69. Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 70. Affine Formulations Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Affine Formulations Limited Business Overview
Table 72. Affine Formulations Limited SWOT Analysis
Table 73. Affine Formulations Limited Recent Developments
Table 74. Aurobindo Pharma Basic Information
Table 75. Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 76. Aurobindo Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Aurobindo Pharma Business Overview
Table 78. Aurobindo Pharma SWOT Analysis
Table 79. Aurobindo Pharma Recent Developments
Table 80. Biocon Limited Basic Information
Table 81. Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 82. Biocon Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biocon Limited Business Overview
Table 84. Biocon Limited Recent Developments
Table 85. Bristol-Myers Squibb Basic Information
Table 86. Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 87. Bristol-Myers Squibb Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Recent Developments
Table 90. Cipla Basic Information
Table 91. Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 92. Cipla Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Cipla Business Overview
Table 94. Cipla Recent Developments
Table 95. Emcure Pharmaceuticals Basic Information
Table 96. Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 97. Emcure Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Emcure Pharmaceuticals Business Overview
Table 99. Emcure Pharmaceuticals Recent Developments
Table 100. Flamingo Pharmaceuticals Limited Basic Information
Table 101. Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 102. Flamingo Pharmaceuticals Limited Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Flamingo Pharmaceuticals Limited Business Overview
Table 104. Flamingo Pharmaceuticals Limited Recent Developments
Table 105. Gilead Sciences Basic Information
Table 106. Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 107. Gilead Sciences Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Gilead Sciences Business Overview
Table 109. Gilead Sciences Recent Developments
Table 110. Hetero Drugs Basic Information
Table 111. Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 112. Hetero Drugs Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hetero Drugs Business Overview
Table 114. Hetero Drugs Recent Developments
Table 115. IPCA Laboratories Basic Information
Table 116. IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 117. IPCA Laboratories Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. IPCA Laboratories Business Overview
Table 119. IPCA Laboratories Recent Developments
Table 120. Janssen Pharmaceutica (Johnson and Johnson) Basic Information
Table 121. Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 122. Janssen Pharmaceutica (Johnson and Johnson) Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Janssen Pharmaceutica (Johnson and Johnson) Business Overview
Table 124. Janssen Pharmaceutica (Johnson and Johnson) Recent Developments
Table 125. LAURUS Labs Basic Information
Table 126. LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 127. LAURUS Labs Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. LAURUS Labs Business Overview
Table 129. LAURUS Labs Recent Developments
Table 130. Medisist Pharma Basic Information
Table 131. Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 132. Medisist Pharma Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Medisist Pharma Business Overview
Table 134. Medisist Pharma Recent Developments
Table 135. Merck Basic Information
Table 136. Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 137. Merck Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Merck Business Overview
Table 139. Merck Recent Developments
Table 140. Mylan Basic Information
Table 141. Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 142. Mylan Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mylan Business Overview
Table 144. Mylan Recent Developments
Table 145. Ranbaxy Pharmaceuticals Basic Information
Table 146. Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 147. Ranbaxy Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Ranbaxy Pharmaceuticals Business Overview
Table 149. Ranbaxy Pharmaceuticals Recent Developments
Table 150. Shanghai Desano Pharmaceuticals Basic Information
Table 151. Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 152. Shanghai Desano Pharmaceuticals Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Shanghai Desano Pharmaceuticals Business Overview
Table 154. Shanghai Desano Pharmaceuticals Recent Developments
Table 155. ViiV Healthcare (GSK) Basic Information
Table 156. ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Product Overview
Table 157. ViiV Healthcare (GSK) Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. ViiV Healthcare (GSK) Business Overview
Table 159. ViiV Healthcare (GSK) Recent Developments
Table 160. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hiv Integrase Strand Transfer Inhibitors (Insti)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD), 2025-2035
Figure 5. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) (2020-2035)
Figure 6. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Product Life Cycle
Figure 13. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Share by Manufacturers in 2025
Figure 14. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Share by Manufacturers in 2025
Figure 15. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue in 2025
Figure 18. Industry Chain Map of Hiv Integrase Strand Transfer Inhibitors (Insti)
Figure 19. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market PEST Analysis
Figure 20. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Type
Figure 27. Sales Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2020-2025)
Figure 28. Sales Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type in 2025
Figure 29. Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2020-2025)
Figure 30. Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application
Figure 33. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application (2020-2025)
Figure 34. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application in 2025
Figure 35. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application (2020-2025)
Figure 36. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application in 2025
Figure 37. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region (2020-2025)
Figure 39. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025)
Figure 40. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 43. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 45. U.S. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 53. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 55. Germany Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region in 2024
Figure 68. China Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 79. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 80. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (M USD)
Figure 81. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 82. Brazil Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region in 2024
Figure 92. Saudi Arabia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production Market Share by Region (2020-2025)
Figure 103. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share Forecast by Type (2026-2035)
Figure 111. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Application (2026-2035)
Figure 112. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Hiv Integrase Strand Transfer Inhibitors (Insti)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD), 2025-2035
Figure 5. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) (2020-2035)
Figure 6. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Product Life Cycle
Figure 13. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Share by Manufacturers in 2025
Figure 14. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue Share by Manufacturers in 2025
Figure 15. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hiv Integrase Strand Transfer Inhibitors (Insti) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hiv Integrase Strand Transfer Inhibitors (Insti) Revenue in 2025
Figure 18. Industry Chain Map of Hiv Integrase Strand Transfer Inhibitors (Insti)
Figure 19. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market PEST Analysis
Figure 20. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Type
Figure 27. Sales Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2020-2025)
Figure 28. Sales Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type in 2025
Figure 29. Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type (2020-2025)
Figure 30. Market Share of Hiv Integrase Strand Transfer Inhibitors (Insti) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application
Figure 33. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application (2020-2025)
Figure 34. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Application in 2025
Figure 35. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application (2020-2025)
Figure 36. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share by Application in 2025
Figure 37. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region (2020-2025)
Figure 39. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region (2020-2025)
Figure 40. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 43. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 45. U.S. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hiv Integrase Strand Transfer Inhibitors (Insti) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 53. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 55. Germany Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region in 2024
Figure 68. China Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 79. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Country in 2024
Figure 80. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (M USD)
Figure 81. South America Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Country in 2024
Figure 82. Brazil Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size by Region in 2024
Figure 92. Saudi Arabia Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Production Market Share by Region (2020-2025)
Figure 103. North America Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Hiv Integrase Strand Transfer Inhibitors (Insti) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share Forecast by Type (2026-2035)
Figure 111. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Sales Forecast by Application (2026-2035)
Figure 112. Global Hiv Integrase Strand Transfer Inhibitors (Insti) Market Share Forecast by Application (2026-2035)
